681
Participants
Start Date
May 21, 2021
Primary Completion Date
July 29, 2025
Study Completion Date
May 10, 2027
Nivolumab and rHuPH20
Specified dose on specified days
Nivolumab
Specified dose on specified days
Local Institution - 0005, Santiago
Local Institution - 0060, Tallaght
Local Institution - 0053, Auckland
Local Institution - 0041, Hamilton
Local Institution - 0078, Palmerston North
Local Institution - 0079, Parana
Local Institution - 0030, Río Cuarto
Local Institution, Nice
Local Institution - 0058, Mar del Plata
Local Institution - 0089, Tlalpan
Local Institution - 0025, Buffalo
Local Institution - 0106, Praha 8 Liben
Local Institution - 0088, West Reading
Local Institution, Milan
Local Institution - 0018, Milan
Local Institution - 0033, Cremona
Local Institution - 0101, Torreón
Local Institution - 0092, Pavia
Local Institution - 0072, Madrid
Local Institution - 0067, Madrid
Local Institution - 0074, Madrid
Local Institution - 0075, Madrid
Local Institution - 0059, Seville
Local Institution - 0017, Tampere
Local Institution - 0019, Istanbul
Local Institution - 0035, Istanbul
Local Institution - 0014, Padua
Local Institution - 0086, Santander
Local Institution - 0082, Parma
Local Institution - 0027, Meldola
Local Institution - 0008, Florence
Local Institution, Chicago
Local Institution - 0103, Monterrey
Local Institution - 0031, Monterrey
Local Institution - 0065, Querétaro
Local Institution - 0085, Querétaro
Local Institution - 0020, Olomouc
Local Institution - 0105, San Luis Potosí City
Local Institution - 0051, Suresnes
Local Institution - 0068, Villejuif
Hertzen Moscow Oncology Research Center, Moscow
Ivanovo Regional Oncology Dispensary, Ivanovo
LLC Eurocityclinic, Saint Petersburg
Local Institution - 0016, Craiova
Local Institution - 0002, Cluj-Napoca
Local Institution - 0040, Cluj-Napoca
SBIH Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine, Chelyabinsk
Local Institution, Nizghiy Novgorod
Budgetary Healthcare Institution of Omsk Region - Clinical Oncological Dispensary, Omsk
Local Institution - 0077, Viña del Mar
Local Institution - 0104, Santiago
Local Institution - 0076, Santiago
Local Institution - 0095, Capital Federal
Local Institution - 0037, Pergamino
Local Institution - 0066, Viedma
Local Institution - 0038, Buenos Aires
Local Institution - 0056, San Juan
Local Institution - 0064, Curitiba
Local Institution - 0107, Ijuí
Local Institution - 0039, Porto Alegre
Local Institution - 0071, Barretos
Local Institution - 0070, São José do Rio Preto
Local Institution - 0090, Rio de Janeiro
Local Institution - 0081, São Paulo
Local Institution - 0096, São Paulo
Local Institution - 0084, Temuco
Local Institution - 0063, Brno
Local Institution - 0036, Hradec Králové
Local Institution - 0099, Ostrava
Local Institution - 0010, Prague
Local Institution - 0100, Roma
Local Institution - 0091, Rome
Local Institution - 0057, Terni
Local Institution - 0055, Biała Podlaska
Local Institution - 0062, Bydgoszcz
Local Institution - 0083, Gdansk
Local Institution - 0021, Krakow
Local Institution - 0098, Krakow
Local Institution - 0001, Poznan
Local Institution - 0023, Warsaw
Local Institution - 0050, Coimbra
Local Institution - 0052, Lisbon
Local Institution - 0024, Bucharest
Local Institution - 0048, Barcelona
Local Institution - 0102, Barcelona
Local Institution - 0049, Barcelona
Local Institution - 0032, Sabadell
Local Institution - 0026, Ankara
Local Institution - 0097, Ankara
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY